Tandem Diabetes (TNDM) reports earnings tomorrow: what to expect

What happened

Tandem Diabetes Care, a diabetes technology company, is scheduled to report earnings on Thursday afternoon. Last quarter, it reported revenue of $254.6 million, up 5.8% year over year, and earnings per share in line with analyst estimates. Analysts expect revenue growth of 5.8% this quarter.

Confirmed

Global impact / market context

The earnings report will show whether Tandem’s revenue growth is keeping pace with expectations, which can shape investors’ view of demand and future sales. Any change to its outlook could also influence expectations for company spending and its ability to fund operations from cash available.

Analyst inference

Analysts generally reconfirmed their estimates in the 30 days before the report, indicating little change in their published expectations. In the healthcare technology segment, Omnicell was the only peer mentioned as having reported; it beat revenue estimates and its stock rose 1.9%.

Confirmed

What to watch

1. Compare reported revenue with the expected 5.8% year-over-year growth; a shortfall could signal weaker sales progress, while a stronger result could support confidence in demand. Analyst inference
2. Check whether Tandem updates its full-year revenue outlook, meaning its forecast for the year; a lower forecast could lead investors to reassess expected sales and spending. Analyst inference
3. Review earnings per share, the company’s profit allocated to each share, against analyst estimates, and note whether the report confirms or changes the pattern from last quarter. Analyst inference

Evidence

• stockstory.org